跳至主要内容
临床试验/NCT07286357
NCT07286357进行中(未招募)不适用

A Multi-Center Retrospective Data Collection Protocol to Evaluate the Real World Usage of the Orthofix AccelStim Device to Treat Fresh Metatarsal Fractures

Orthofix Inc.3 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年5月30日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Orthofix Inc.
入组人数
100
试验地点
3
主要终点
Healing Status

研究概览

简要总结

This study examines the effect of using the AccelStim bone growth stimulator on subjects undergoing treatment for fresh metatarsal fractures.

详细描述

The objective of this investigation is to study the effect of using LIPUS treatment (via AccelStim) in subjects with fresh metatarsal fractures. The sponsor hypothesizes that use of AccelStim will result in higher rates of fusion compared to that of control. In addition to analyzing the primary endpoint, the study will collect safety information to confirm the favorable safety profile established in prior device usage.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Fresh metatarsal fracture patient that has been prescribed an Orthofix AccelStim device
  • Patient is 18 years or older at the time of treatment

排除标准

  • Patient is a prisoner

结局指标

主要结局

Healing Status

时间窗: 3, 6, and 12 month

Quantitative and qualitative assessments of clinical and radiographic healing (as available per standard of care)

次要结局

  • Pain (NPRS) (0-100)(Baseline, 3, 6, and 12 month)

研究者

发起方
Orthofix Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验